Louis Dwomoh

Glasgow, SCT, United Kingdom

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 12 publications

Phosphorylation bar-coding of free fatty acid receptor 2 is generated in a tissue-specific manner.

Phosphorylation bar-coding of free fatty acid receptor 2 is generated in a tissue-specific manner.

Journal: eLife

Published: December 12, 2023

M1 muscarinic receptor activation reduces the molecular pathology and slows the progression of prion-mediated neurodegenerative disease.

M1 muscarinic receptor activation reduces the molecular pathology and slows the progression of prion-mediated neurodegenerative disease.

Journal: Science signaling

Published: November 15, 2022

Targeting the M1 muscarinic acetylcholine receptor in Alzheimer's disease.

Targeting the M1 muscarinic acetylcholine receptor in Alzheimer's disease.

Journal: Neuronal signaling

Published: February 02, 2022

Selective phosphorylation of threonine residues defines GPR84-arrestin interactions of biased ligands.

Selective phosphorylation of threonine residues defines GPR84-arrestin interactions of biased ligands.

Journal: The Journal of biological chemistry

Published: November 26, 2021

Investigating protein expression, modifications and interactions in the brain: Protocol for preparing rodent brain tissue for mass spectrometry-based quantitative- and phospho-proteomics analysis.

Investigating protein expression, modifications and interactions in the brain: Protocol for preparing rodent brain tissue for mass spectrometry-based quantitative- and phospho-proteomics analysis.

Journal: Methods in cell biology

Published: November 09, 2021

Host tissue proteomics reveal insights into the molecular basis of Schistosoma haematobium-induced bladder pathology.

Host tissue proteomics reveal insights into the molecular basis of Schistosoma haematobium-induced bladder pathology.

Journal: PLoS neglected tropical diseases

Published: November 08, 2021

Biased M1 muscarinic receptor mutant mice show accelerated progression of prion neurodegenerative disease.

Biased M1 muscarinic receptor mutant mice show accelerated progression of prion neurodegenerative disease.

Journal: Proceedings of the National Academy of Sciences of the United States of America

Published: October 04, 2021

From structure to clinic: Design of a muscarinic M1 receptor agonist with potential to treatment of Alzheimer's disease.

From structure to clinic: Design of a muscarinic M1 receptor agonist with potential to treatment of Alzheimer's disease.

Journal: Cell

Published: June 19, 2020

Inhibition of Resistance-Refractory P. falciparum Kinase PKG Delivers Prophylactic, Blood Stage, and Transmission-Blocking Antiplasmodial Activity.

Inhibition of Resistance-Refractory P. falciparum Kinase PKG Delivers Prophylactic, Blood Stage, and Transmission-Blocking Antiplasmodial Activity.

Journal: Cell chemical biology

Published: February 15, 2020

Biased M1-muscarinic-receptor-mutant mice inform the design of next-generation drugs.

Biased M1-muscarinic-receptor-mutant mice inform the design of next-generation drugs.

Journal: Nature chemical biology

Published: June 12, 2019

Bitopic Binding Mode of an M1 Muscarinic Acetylcholine Receptor Agonist Associated with Adverse Clinical Trial Outcomes.

Bitopic Binding Mode of an M1 Muscarinic Acetylcholine Receptor Agonist Associated with Adverse Clinical Trial Outcomes.

Journal: Molecular pharmacology

Published: January 24, 2018

Variants of the EAAT2 Glutamate Transporter Gene Promoter Are Associated with Cerebral Palsy in Preterm Infants.

Variants of the EAAT2 Glutamate Transporter Gene Promoter Are Associated with Cerebral Palsy in Preterm Infants.

Journal: Molecular neurobiology

Published: July 08, 2016

Showing 1-12 of 12

Last Updated: 09/26/2026